Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RXRX Recursion Pharmaceuticals, Inc.

盘后交易 09-01 19:55:26 EDT

3.33

-0.07

-2.06%

盘后3.34

+0.01+0.26%

19:53 EDT

最高3.38	最低3.28	成交量999.65万
今开3.34	昨收3.40	日振幅2.94%
总市值17.82亿	流通市值17.39亿	总股本5.35亿
成交额3,334万	换手率1.91%	流通股本5.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":3.33,"timestamp":1788292800000,"preClose":3.4,"halted":0,"volume":9996545,"hourTrading":{"tag":"盘后","latestPrice":3.3386,"preClose":3.33,"latestTime":"19:53 EDT","volume":438721,"amount":1460929.1722772,"timestamp":1788306791629,"change":0.0086,"changeRate":0.002583,"amplitude":0.008859},"delay":0,"changeRate":-0.0205882352941176,"floatShares":522325546,"shares":534999999,"eps":-1.021913,"marketStatus":"盘后交易","change":-0.07,"latestTime":"09-01 19:55:26 EDT","open":3.34,"high":3.38,"low":3.2801,"amount":33343418.8671935,"amplitude":0.029382,"askPrice":3.34,"askSize":525,"bidPrice":3.33,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-1.021913,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":3.4,"preHourTrading":{"tag":"盘前","latestPrice":3.34,"preClose":3.4,"latestTime":"09:29 EDT","volume":175239,"amount":583116.7797846,"timestamp":1788269399999,"change":-0.06,"changeRate":-0.017647,"amplitude":0.029412},"postHourTrading":{"tag":"盘后","latestPrice":3.3386,"preClose":3.33,"latestTime":"19:53 EDT","volume":438721,"amount":1460929.1722772,"timestamp":1788306791629,"change":0.0086,"changeRate":0.002583,"amplitude":0.008859},"volumeRatio":0.704434,"impliedVol":0.9322,"impliedVolPercentile":0.623},"requestUrl":"/m/hq/s/RXRX","defaultTab":"news","newsList":[{"id":"1133649053","title":"Recursion Pharmaceuticals第二季度运营收入730.3万美元，低于IBES预期1190万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133649053","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133649053?lang=zh_cn&edition=full","pubTime":"2026-08-05 18:45","pubTimestamp":1785926738,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals（RXRX）公布了第二季度财务数据。其运营收入仅为730.3万美元，远低于IBES估算的1190万美元。此外，该公司在报告期内录得税前亏损1.31006亿美元。这一业绩表现与市场预期存在显著差距，反映出公司当前面临的挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4139","BK4611","BK4548","BK4609","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160129009","title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1160129009","media":"华尔街见闻","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160129009?lang=zh_cn&edition=full","pubTime":"2026-04-17 07:06","pubTimestamp":1776380807,"startTime":"0","endTime":"0","summary":"OpenAI正式进军AI辅助药物研发领域，向谷歌等竞争对手发起挑战，并引发相关上市公司股价大幅下挫。OpenAI还宣布对旗下Codex产品进行更新，新版本支持与用户协同操控电脑，兼容更多常用工具与应用，并可记忆用户偏好、学习历史操作习惯。不过，Joy Jiao同时强调，OpenAI目前并不认为AI可以独立提出新的疾病治疗方案。Codex更新：拓展日常工具协作能力OpenAI发布Codex更新。","market":"us","thumbnail":"https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3770180","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1762389672944","symbols":["SDGR","IQV","RXRX","CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164927646","title":"Recursion Pharmaceuticals任命Vicki Goodman为首席医疗官，2026年4月6日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1164927646","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164927646?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:00","pubTimestamp":1774440051,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc. 宣布一项重要人事任命：Vicki Goodman将于2026年4月6日正式加入公司，担任首席医疗官一职。此次任命标志着公司在临床开发与医疗战略方面的进一步强化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4611","BK4539","RXRX","BK4609","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620427366","title":"“木头姐”发声：AI已开始重塑生产力，未来十年将创造12万亿美元收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2620427366","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2620427366?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:58","pubTimestamp":1773759492,"startTime":"0","endTime":"0","summary":"ARK创始人Cathie Wood表示，AI正切实拉动生产率；美国非农生产率已实现2.8%的同比增长，随着AI工具加速落地应用，未来增速有望翻倍至6%。她预测未来十年AI赛道将创造超10到12万亿美元收入，将对全球GDP产生实质性拉动。","market":"us","thumbnail":"https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3767748","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARM","NVDA","NNOX","AUR","BK4585","SERV","BK4544","RXRX","BK4594","APLD","INVZ","TM","ARBE","BK4588","CRNC","SOUN","NBIS","BK4601","MU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2518222608","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518222608?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613625,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.08%。截至发稿，该股报6.26美元/股，成交量116.678万股，换手率0.29%，振幅2.43%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2084.06%、406.02%、63.10%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为100.05%、99.13%、98.72%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213345a26a2579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213345a26a2579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4609","RXRX","BK4611","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516677104","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.16%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677104?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098737,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.16%。截至发稿，该股报6.25美元/股，成交量282.348万股，换手率0.70%，振幅1.90%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1048.08%、1033.73%、409.49%，振幅较大的相关个股有Adma Biologics Inc、Ocean Biomedical, Inc.、Aditxt, Inc.，振幅分别为11.75%、10.39%、9.50%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422321796394489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422321796394489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXRX","BK4548","BK4539","BK4609","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630506","title":"Recursion Pharmaceuticals, Inc.盘中异动 快速跳水5.06%报7.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516630506?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:14","pubTimestamp":1741014893,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时14分，Recursion Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.06%。截至发稿，该股报7.13美元/股，成交量584.537万股，换手率1.45%，振幅9.99%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1588.23%、132.29%、107.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032314549637b807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032314549637b807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4548","RXRX","BK4609","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516022813","title":"Leerink Partners：维持Recursion Pharmaceuticals(RXRX.US)评级，由大市一致调整至大市一致评级, 目标价由7.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516022813","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516022813?lang=zh_cn&edition=full","pubTime":"2025-03-01 05:47","pubTimestamp":1740779249,"startTime":"0","endTime":"0","summary":"Leerink Partners：维持Recursion Pharmaceuticals(RXRX.US)评级，由大市一致调整至大市一致评级, 目标价由7.00美元调整至6.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01054748470353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108509860","title":"盘前｜英伟达持仓股齐跌，RXRX跌超12%；今晚美联储“首选通胀指标”来袭","url":"https://stock-news.laohu8.com/highlight/detail?id=1108509860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108509860?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:44","pubTimestamp":1740746647,"startTime":"0","endTime":"0","summary":"报告充斥着诸多不实之词$英伟达$盘前由涨转跌，其持仓概念股纷纷下挫，RXRX跌超12%明星中概股普跌，$小鹏汽车$跌超7%财报股表现：SoundHound AI涨超3%，$戴尔$跌近4%，RKLB跌超15%2月28日，美股三大股指期货上涨，截止发稿，道指期货涨0.37%，纳指期货涨0.06%，标普500指数期货涨0.24%。盘前行情英伟达盘前由涨转跌，其持仓概念股纷纷下挫，Recursion Pharmaceuticals跌超12%，$NEBIUS$跌超4%，Applied Digital跌近4%，$文远知行$跌超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XPEV","RXRX","IE00BJJMRX11.SGD","IE0009356076.USD","BK4579","BK4555","NVDA","IE0004091025.USD","BK1119","BK4550","IE00BHPRN162.USD","IE0004086264.USD","IE00BKVL7J92.USD","BK4588","BK4533","BK4587","RKLB","GB00BDT5M118.USD","BK1539"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1127500860","title":"Recursion Pharmaceuticals盘前跌超11%，Q4营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1127500860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127500860?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:09","pubTimestamp":1740744598,"startTime":"0","endTime":"0","summary":"2月28日，Recursion Pharmaceuticals盘前跌超11%，财报显示：2024年第四季度营业收入为451.1万美元，不及市场预期，去年同期1062.4万美元。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion Pharmaceuticals盘前跌超11%，Q4营收不及预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4548","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105563112","title":"异动解读 | RXRX盘前大跌5.87%,业绩低于预期或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1105563112","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105563112?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:40","pubTimestamp":1740742851,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals(纳斯达克:RXRX)于周五盘前大跌5.87%,引发了市场广泛关注。\n公司近期公布的2022年第四季度财报显示,每股亏损0.53美元,远超分析师预期的0.46美元亏损。营收方面,RXRX季度销售额仅为455万美元,大幅低于市场预期的1904万美元。\n这一业绩低于预期的情况可能是导致盘前股价大跌的主要原因。不过,目前尚未有其他公开信息可以解释这一跌幅。投资者或需进一步关注公司未来发展,以判断是否存在更深层次的影响因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137020833","title":"Recursion Pharmaceuticals 第四季度每股收益 $(0.53) 不及预期 $(0.46)，销售额 $4.55M 低于预期 $19.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=1137020833","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137020833?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:36","pubTimestamp":1740742604,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals报告季度每股亏损 $，与分析师共识预期的 $ 相比，低了15.22%。与去年同期每股亏损 $ 相比下降了26.19%。以上内容来自Benzinga Earnings专栏，原文如下：Recursion Pharmaceuticals  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 15.22 percent. This is a 26.19 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $4.55 million which missed the analyst consensus estimate of $19.04 million by 76.13 percent.  This is a 58.26 percen","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Recursion Pharmaceuticals 第四季度每股收益 $(0.53) 不及预期 $(0.46)，销售额 $4.55M 低于预期 $19.04M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514867334","title":"Recursion Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514867334?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:32","pubTimestamp":1740684731,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时32分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.04%。截至发稿，该股报7.92美元/股，成交量1706.36万股，换手率4.37%，振幅7.67%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Heron Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1902.95%、330.28%、183.35%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280332129632e84e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280332129632e84e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4609","RXRX","BK4139","BK4548","BK4539"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514851810","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘急速上涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514851810?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Recursion Pharmaceuticals, Inc.股票出现波动，股价大幅上涨6.08%。截至发稿，该股报8.64美元/股，成交量224.996万股，换手率0.58%，振幅1.97%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2782.30%、115.75%、90.27%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为28.81%、16.85%、14.35%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223205abddecd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223205abddecd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXRX","BK4139","BK4609","BK4548"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514090413","title":"Recursion Pharmaceuticals, Inc.盘中异动 大幅下跌5.44%报8.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090413?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493861,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Recursion Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.44%。截至发稿，该股报8.51美元/股，成交量147.616万股，换手率0.38%，振幅0.23%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为746.06%、508.58%、459.43%，振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Bicara Therapeutics Inc.，振幅分别为8.10%、7.46%、5.62%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223101a253864d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223101a253864d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4609","RXRX","BK4548","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2513952720","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报8.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513952720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513952720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:01","pubTimestamp":1740409285,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时01分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.16%。截至发稿，该股报8.80美元/股，成交量1012.6万股，换手率2.59%，振幅10.13%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为154.64%、68.82%、25.12%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230125a2521bcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230125a2521bcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4609","RXRX","BK4139","BK4548"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2513729417","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大跌5.00%报9.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513729417?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:37","pubTimestamp":1740152268,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时37分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.00%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为176.58%、112.02%、35.18%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为57.50%、48.19%、36.69%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233748962b8a74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233748962b8a74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4548","BK4609","RXRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2512836424","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512836424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512836424?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:32","pubTimestamp":1739975538,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时32分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.09%。截至发稿，该股报11.18美元/股，成交量415.395万股，换手率1.06%，振幅3.81%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为210.89%、203.17%、65.69%，振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、Opthea Limited，振幅分别为27.65%、11.29%、11.01%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223218a24bf9a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223218a24bf9a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RXRX","BK4548"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2512654241","title":"Recursion Pharmaceuticals, Inc.股价飙升11.59% 市值涨5.22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512654241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512654241?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:36","pubTimestamp":1739889372,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时36分，Recursion Pharmaceuticals, Inc.股票出现异动，股价急速上涨11.59%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为286.27%、101.06%、76.03%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为34.04%、22.30%、21.34%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223612abd3b046&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223612abd3b046&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4548","RXRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1151000669","title":"美股夜盘｜英伟达持仓股、AI医疗股续涨；Grab绩前抢跑，飙涨逾16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151000669","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151000669?lang=zh_cn&edition=full","pubTime":"2025-02-18 09:09","pubTimestamp":1739840971,"startTime":"0","endTime":"0","summary":"2月18日，美股夜班时段，英伟达新进仓股Nebius美股夜盘续涨超6%，该股上一交易日收涨近7%.AI医疗股延续涨势，Reduction in Recursion涨超9%，Hims & Hers Health涨超4%，热门中概股多数下跌，百度、哔哩哔哩跌超5%，京东跌超2%。东南亚网约车巨头Grab涨超16%，该股将于本周三美股盘后发布最新季度业绩。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","IE00B19Z8X17.USD","IE00BDRTCR15.USD","LU2045819591.USD","RXRX","BK4592","IE00BD6J9T35.USD","IE00B1BXHZ80.USD","IE00BMPRXQ63.HKD","BK4529","NBIS","LU2125910500.SGD","IE00BFSS8Q28.SGD","GRAB","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","IE00BK4W5M84.HKD","IE00BK4W5L77.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.recursion.com;ir.recursion.com","stockEarnings":[{"period":"1week","weight":0.0462},{"period":"1month","weight":0.1333},{"period":"3month","weight":-0.0582},{"period":"6month","weight":-0.0659},{"period":"1year","weight":-0.2766},{"period":"ytd","weight":-0.1687}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0268},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1196},{"period":"1year","weight":0.1891},{"period":"ytd","weight":0.1248}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Recursion Pharmaceuticals, Inc.最初成立于2013年11月4日，并在特拉华州注册成立 。 该公司是一家领先的临床阶段TechBio公司，将生物解码以将药物发现产业化。公司使命的核心是递归操作系统（OS），这是一个跨多种技术构建的平台，使公司能够在超过50 PB的专有数据中绘制和导航数万亿个以生物、化学和患者为中心的关系。该公司将物理和数字组件的这种集成框定为迭代循环，其中规模化的“湿实验室”生物学、化学和以患者为中心的实验数据由“干实验室”计算工具组织，以便识别、验证和翻译治疗见解。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035717},{"month":2,"riseRate":0.4,"avgChangeRate":0.049361},{"month":3,"riseRate":0,"avgChangeRate":-0.249219},{"month":4,"riseRate":0.4,"avgChangeRate":-0.090167},{"month":5,"riseRate":0.5,"avgChangeRate":0.076509},{"month":6,"riseRate":0.666667,"avgChangeRate":0.117519},{"month":7,"riseRate":0.666667,"avgChangeRate":0.141285},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.083252},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050486},{"month":10,"riseRate":0.2,"avgChangeRate":-0.079168},{"month":11,"riseRate":0.4,"avgChangeRate":0.028843},{"month":12,"riseRate":0.2,"avgChangeRate":-0.000986}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}